Trending Stock News

Castlight Health, Inc. (CSLT) EPS Estimated At $-0.11; Coherent, Inc. (COHR) Covered By 7 Bullish Analysts Last Week

Coherent, Inc. (NASDAQ:COHR) Logo

Among 7 analysts covering Coherent (NASDAQ:COHR), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Coherent had 29 analyst reports since August 3, 2015 according to SRatingsIntel. Stifel Nicolaus maintained Coherent, Inc. (NASDAQ:COHR) on Monday, March 7 with “Buy” rating. The stock of Coherent, Inc. (NASDAQ:COHR) has “Buy” rating given on Thursday, November 3 by Needham. On Thursday, February 8 the stock rating was maintained by Needham with “Buy”. The stock has “Buy” rating by Barclays Capital on Monday, August 7. Barclays Capital maintained Coherent, Inc. (NASDAQ:COHR) rating on Thursday, February 8. Barclays Capital has “Overweight” rating and $325 target. The rating was maintained by Needham with “Buy” on Wednesday, August 2. Barclays Capital maintained Coherent, Inc. (NASDAQ:COHR) on Wednesday, November 8 with “Overweight” rating. The firm has “Buy” rating given on Monday, June 12 by Longbow. The firm has “Positive” rating by Susquehanna given on Thursday, August 3. The company was maintained on Thursday, November 10 by Benchmark. See Coherent, Inc. (NASDAQ:COHR) latest ratings:

12/02/2018 Broker: Northcoast Rating: Buy New Target: $314.0 Maintain
08/02/2018 Broker: Susquehanna Rating: Buy New Target: $310.0 Maintain
08/02/2018 Broker: Needham Rating: Buy New Target: $294.0 Maintain
08/02/2018 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Buy Old Target: $330 New Target: $310 Maintain
08/02/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $332 New Target: $325 Maintain
08/11/2017 Broker: Needham Rating: Buy New Target: $330.0 Maintain
08/11/2017 Broker: Barclays Capital Rating: Overweight Old Target: $285 New Target: $315 Maintain
08/11/2017 Broker: Stifel Nicolaus Rating: Buy Old Target: $290 New Target: $330 Maintain

Analysts expect Castlight Health, Inc. (NYSE:CSLT) to report $-0.11 EPS on May, 10 after the close.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.11 EPS. After having $-0.05 EPS previously, Castlight Health, Inc.’s analysts see 120.00% EPS growth. The stock increased 2.00% or $0.08 during the last trading session, reaching $3.83. About 77,459 shares traded. Castlight Health, Inc. (NYSE:CSLT) has risen 6.15% since May 1, 2017 and is uptrending. It has underperformed by 5.40% the S&P500.

Castlight Health, Inc. operates a health benefits platform in the United States. The company has market cap of $518.66 million. The company's platform engages employees to make better health decisions and enables employers to communicate and measure their benefit programs. It currently has negative earnings. The Company’s platform also provides real-time insight into employee engagement with benefits and programs enabling employers to monitor and adjust their strategies.

Among 13 analysts covering Castlight Health (NYSE:CSLT), 7 have Buy rating, 1 Sell and 5 Hold. Therefore 54% are positive. Castlight Health had 33 analyst reports since October 9, 2015 according to SRatingsIntel. Morgan Stanley downgraded the stock to “Underweight” rating in Friday, May 12 report. Canaccord Genuity maintained Castlight Health, Inc. (NYSE:CSLT) rating on Friday, June 30. Canaccord Genuity has “Hold” rating and $500 target. The stock of Castlight Health, Inc. (NYSE:CSLT) has “Hold” rating given on Monday, November 6 by Cantor Fitzgerald. The stock of Castlight Health, Inc. (NYSE:CSLT) has “Buy” rating given on Wednesday, February 21 by Cantor Fitzgerald. The stock of Castlight Health, Inc. (NYSE:CSLT) has “Hold” rating given on Thursday, August 3 by Canaccord Genuity. First Analysis upgraded the shares of CSLT in report on Friday, October 9 to “Overweight” rating. The stock has “Buy” rating by Stifel Nicolaus on Thursday, November 5. The firm has “Buy” rating given on Wednesday, December 16 by Topeka Capital Markets. Raymond James downgraded the shares of CSLT in report on Thursday, January 5 to “Mkt Perform” rating. The stock of Castlight Health, Inc. (NYSE:CSLT) has “Buy” rating given on Thursday, October 26 by Chardan Capital Markets.

Since February 15, 2018, it had 0 insider buys, and 4 insider sales for $120,817 activity. DOYLE JOHN C had sold 10,644 shares worth $38,624. 18,201 Castlight Health, Inc. (NYSE:CSLT) shares with value of $66,124 were sold by Nolan Mangini Siobhan.

Investors sentiment decreased to 1.23 in 2017 Q4. Its down 0.82, from 2.05 in 2017Q3. It is negative, as 10 investors sold Castlight Health, Inc. shares while 21 reduced holdings. 16 funds opened positions while 22 raised stakes. 46.25 million shares or 3.11% more from 44.86 million shares in 2017Q3 were reported. Alliancebernstein L P invested 0% of its portfolio in Castlight Health, Inc. (NYSE:CSLT). Wells Fargo Commerce Mn has 40,209 shares. 634,885 are held by Alyeska Investment Gp Ltd Partnership. Rhumbline Advisers invested in 55,402 shares or 0% of the stock. Acadian Asset Management Limited Liability Co holds 0% or 8,904 shares in its portfolio. 184 are held by Qs Invsts Ltd Limited Liability Company. Gagnon Advsrs Limited Liability Corp reported 901,394 shares stake. Barclays Public Ltd Company reported 10,157 shares. Balyasny Asset Management Limited Liability invested in 0% or 13,400 shares. Ameritas Invest reported 0% of its portfolio in Castlight Health, Inc. (NYSE:CSLT). Metropolitan Life Insurance New York holds 0% in Castlight Health, Inc. (NYSE:CSLT) or 12,135 shares. Tiaa Cref Invest Management Limited Liability Co has invested 0% of its portfolio in Castlight Health, Inc. (NYSE:CSLT). Selz Lc, New York-based fund reported 734,000 shares. First Quadrant Lp Ca holds 44,537 shares or 0% of its portfolio. Tower Limited (Trc) holds 0.01% or 14,190 shares.

Investors sentiment decreased to 1.02 in 2017 Q4. Its down 0.01, from 1.03 in 2017Q3. It turned negative, as 43 investors sold Coherent, Inc. shares while 111 reduced holdings. 60 funds opened positions while 97 raised stakes. 22.70 million shares or 2.26% less from 23.23 million shares in 2017Q3 were reported. Metropolitan Life Insur Ny has invested 0.03% of its portfolio in Coherent, Inc. (NASDAQ:COHR). Employees Retirement Systems Of Texas has 0.03% invested in Coherent, Inc. (NASDAQ:COHR). First Tru L P has 0.08% invested in Coherent, Inc. (NASDAQ:COHR). Rhumbline Advisers holds 55,905 shares. King Luther Mgmt holds 0.01% or 5,445 shares. Clarivest Asset Mgmt Limited Liability Com holds 0.05% or 10,809 shares in its portfolio. Paradigm Asset Mgmt Limited Liability Company has invested 0.02% in Coherent, Inc. (NASDAQ:COHR). Btim has invested 0.34% in Coherent, Inc. (NASDAQ:COHR). Product Prns Ltd Liability Corp has 0.53% invested in Coherent, Inc. (NASDAQ:COHR) for 64,892 shares. Moreover, Intrust Comml Bank Na has 0.12% invested in Coherent, Inc. (NASDAQ:COHR) for 1,381 shares. First Mercantile Trust Co accumulated 704 shares. Dupont Cap Mgmt Corp, a Delaware-based fund reported 1,298 shares. Skylands Capital Ltd Liability Com owns 148,500 shares or 5.4% of their US portfolio. Epoch Invest Partners owns 590,481 shares. Hanson & Doremus Inv Mgmt invested in 0% or 20 shares.

Since January 4, 2018, it had 0 buys, and 2 selling transactions for $517,735 activity. Another trade for 1,372 shares valued at $411,600 was made by Sechrist Paul F on Thursday, January 4. On Monday, February 12 SKAGGS STEPHEN A sold $106,135 worth of Coherent, Inc. (NASDAQ:COHR) or 500 shares.

Coherent, Inc. (NASDAQ:COHR) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *